Welcome to our dedicated page for Verisk Analytics SEC filings (Ticker: VRSK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Verisk Analytics, Inc. (VRSK) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Verisk’s common stock is registered on the Nasdaq Global Select Market under the symbol VRSK, and its Form 8-K filings and other reports offer insight into material events, capital structure, and financial performance. These documents are a primary source for understanding how Verisk reports its results, manages financing arrangements, and documents significant corporate actions.
Verisk’s recent Form 8-K filings include reports of quarterly financial results, where the company furnishes press releases detailing revenue, net income, adjusted EBITDA, and segment performance for underwriting and claims within its Insurance segment. These filings also describe drivers of growth, such as forms, rules and loss cost services, extreme event solutions, anti-fraud solutions, and casualty solutions. Other 8-Ks document material definitive agreements, including term credit agreements and amended and restated revolving credit facilities, as well as the issuance of senior notes under a shelf registration statement to finance planned acquisitions.
Filings related to acquisitions and capital markets activity are particularly relevant for Verisk. For example, the company filed an 8-K describing an Agreement and Plan of Merger to acquire Exactlogix, Inc. (AccuLynx.com), and another 8-K outlining the issuance of 4.500% senior notes due 2030 and 5.125% senior notes due 2036, along with associated indentures and underwriting agreements. A later news release explains that Verisk terminated its definitive agreement to purchase AccuLynx and plans to redeem the acquisition-related notes under a special mandatory redemption provision, illustrating how these filings connect to subsequent corporate decisions.
On Stock Titan, these filings are supplemented by AI-powered summaries that highlight the key points of each document, helping users quickly understand the significance of complex agreements, financing terms, and financial disclosures. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured access to exhibits such as credit agreements, indentures, and merger agreements allows deeper analysis when needed. For investors, analysts, and insurance professionals researching VRSK, this page centralizes Verisk’s official SEC communications, including information on debt obligations, credit facilities, merger agreements, and periodic financial reporting.
Verisk Analytics (VRSK) filed a Form 144 notifying the proposed sale of 1,100 shares of common stock through Merrill Lynch on NASDAQ, with an aggregate market value of $294,800 and an approximate sale date of 08/15/2025. The shares were acquired via vesting of restricted stock units on 04/01/2021 (748 shares) and 11/14/2021 (352 shares) as part of the issuer's equity compensation plan. The filing reports no securities sold in the past 3 months. Certain fields such as the filer CIK/CCC and the filer’s stated relationship to the issuer are not provided in the form content.
Form 144 notice by an insider of Verisk Analytics, Inc. (VRSK) reporting proposed sales of common stock. The filing shows 300 shares to be sold through Merrill Lynch (225 Liberty St, New York) with an aggregate market value of $80,400 and an approximate sale date of 08/15/2025 on NASDAQ. The shares were acquired on 10/01/2023 upon vesting of a restricted stock unit award granted as part of the issuer's equity compensation plan. The filer also disclosed two recent sales by the same person: 300 shares sold 06/17/2025 for $92,670 and 300 shares sold 07/15/2025 for $91,164. The notice includes the standard insider representation that the seller is not aware of undisclosed material adverse information.
Form 4 summary: Verisk Analytics director Christopher John Perry reported an open-market purchase of 1,000 shares of Verisk Analytics, Inc. (VRSK) on 08/13/2025 at a price of $259.80 per share. Following the transaction, Mr. Perry beneficially owns 1,773 shares in a direct capacity. The filing indicates it was signed on behalf of the reporting person by an attorney-in-fact on 08/14/2025. The Form 4 shows a single non-derivative acquisition and does not disclose any other changes or derivative positions.
Verisk Analytics is offering $1.5 billion of senior notes—$750 million of 4.500% notes due August 15, 2030 and $750 million of 5.125% notes due February 15, 2036—to finance its announced $2.35 billion cash acquisition of AccuLynx, a cloud software provider for roofing contractors. Interest accrues from August 21, 2025 and will be paid semi-annually on February 15 and August 15 beginning February 15, 2026.
The sale is not conditioned on closing the Acquisition; if the Acquisition is not completed by the specified Special Mandatory Redemption End Date or the Merger Agreement is terminated, Verisk must redeem the notes in full at 101% of principal plus accrued interest. The company has a committed bridge facility up to $1.5 billion and expects a new $750 million term loan and an amended revolving facility up to $1.25 billion as additional financing sources. As of June 30, 2025, Verisk reported $628.7 million cash, $3,250.2 million total debt and six‑month net income attributable to Verisk of $485.6 million; pro forma indebtedness after the offering and expected borrowing would be approximately $5,500.2 million, increasing leverage.
Offering and Transaction: Verisk filed a prospectus supplement for an offering of two series of senior notes (terms and amounts redacted in this document) and intends to use net proceeds, together with borrowings under a contemplated New Term Loan Facility and cash on hand, to finance its announced acquisition of Exactlogix, Inc. d/b/a AccuLynx for a cash purchase price of $2.35 billion. The notes are unsecured, unsubordinated, will not be guaranteed by subsidiaries and are a new issue with no established trading market.
Financing and timing: The company has a commitment letter for a senior unsecured 364-day bridge facility of up to $1.5 billion, expects to obtain a senior unsecured three-year delayed draw New Term Loan Facility of up to $750 million, and intends to amend its revolving facility to up to $1.25 billion. The Acquisition is expected to close in the third quarter of 2025.
- Key financials (reported): Revenues six months ended June 30, 2025: $1,525.6m. Net income attributable to Verisk (six months): $485.6m. Cash and cash equivalents as of June 30, 2025: $628.7m. Total debt as of June 30, 2025: $3,250.2m. EBITDA (six months): $861.6m.
- Pro forma leverage: The filing states pro forma consolidated indebtedness would be approximately $5,500.2m after giving effect to this offering and expected New Term Loan borrowings.
- Material terms/risks: There is no escrow or security interest in offering proceeds for noteholders; if the Acquisition is not consummated by specified dates or is terminated, a Special Mandatory Redemption may require repayment in full at 101% of principal plus accrued interest. Notes may also be repurchased upon certain change-of-control events.
Verisk Analytics (VRSK) – Form 4 insider transaction
CEO & director Lee Shavel reported a single 08/01/2025 transaction coded “G,” denoting a bona-fide gift of 1,800 common shares at $0.00. His direct holding declines to 81,107 shares, roughly 2.2 % of his prior stake and far below 0.01 % of Verisk’s total shares outstanding. No derivative activity, sales for consideration, or Rule 10b5-1 plan were disclosed. The charitable transfer is routine and carries negligible balance-sheet or ownership impact; thus, it is unlikely to influence valuation or trading dynamics.